Interaction Guide · Research summary

Can I take Paullinia Cupana with Methamphetamine?

Review Paullinia Cupana with Methamphetamine: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Guarana can add caffeine to your stimulant exposure. Review it with your pharmacist before use with methamphetamine, especially in an energy or weight-loss blend. The exact combination has not been shown to cause QT prolongation or arrhythmia.

What this answer covers

Paullinia cupana seed preparations; assess measured caffeine and other ingredients rather than assuming all extracts are equivalent.

Supplement or preparation
Paullinia cupana
Medication ingredient
methamphetamine

Include guarana in your caffeine total

Guarana seed contains caffeine. The amount in a commercial serving depends on the product, and a blend may add more caffeine. Show the full label to your pharmacist.

Do not confuse a blend with guarana alone

A controlled study found increased blood pressure and pulse with ephedra-guarana preparations. It cannot isolate guarana, and it did not test methamphetamine.

What the safety update means

The European review noted palpitations reports plausibly related to caffeine. These reports do not establish a QT interaction or measure risk from the requested pair. There is no proven spacing interval that prevents symptoms.

Symptoms that need attention

Seek urgent medical care for chest pain, shortness of breath or fainting while taking methamphetamine. Tell your prescriber about new palpitations, troublesome stimulation or sleep disruption, and let the treating team decide on medication changes.

Evidence and practical considerations

Side effects & toxicity

Caffeine-related precautions are reasonable, but combined guarana and methamphetamine cardiovascular harm has not been directly measured.

Exact scope
Paullinia cupana seed preparations; assess measured caffeine and other ingredients rather than assuming all extracts are equivalent. with Prescribed oral S-methamphetamine hydrochloride; RxNorm 6816 IN and label section 11 establish active-moiety relationship, not dose or stereoisomer interchangeability.
Medication form and route
oral
Timing or duration
Dose, pattern of use and preparation matter; no universal protective spacing interval established.

What remains uncertain

  • Ephedra-guarana trials cannot isolate guarana or transfer the effect to methamphetamine. Spontaneous reports do not quantify pair risk.

Factors that may matter: exact product; other medicines; prescribed dose; baseline cardiovascular or serotonergic risk.

Research conclusion: supported with conditions · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed oral methamphetamine hydrochloride tablets.

Sections 2.4 and 7.1 identify acidifying agents such as ascorbic acid as lowering levels and alkalinizing agents such as sodium bicarbonate as increasing levels; avoid gastrointestinal and urinary alkalinizing co-use. Sections 5.8 and 7.1 warn about serotonin syndrome with serotonergic agents, specifically including tryptophan and St Johns wort. Section 5.3 calls for blood-pressure and pulse monitoring.

How this applies: RxNorm 6816 IN maps to this SPL, and description confirms active ingredient salt relationship. Applies to prescribed oral S-methamphetamine hydrochloride, not other stimulants or unapproved routes.

Regulatory guidance is not a quantified trial for every named pair. No one-hour supplement spacing instruction. General amphetamine language is explicitly incorporated in this exact methamphetamine product label.

Source 2: official guidance

ema.europa.eu · Source check Sep 10, 2026

Population: People considering the specified supplement.

Identifies caffeine in guarana seed; a pharmacopoeial seed specification requires at least 3.5% caffeine.

How this applies: Guarana seed constituent and safety context only, not a methamphetamine study.

A raw-material specification is not the caffeine amount in every commercial serving. No methamphetamine study.

Source 3: official guidance

ema.europa.eu · Source check Sep 10, 2026

Population: People considering the specified supplement.

Review noted palpitations reports plausibly related to caffeine and no new safety concern requiring monograph revision. Rat amiodarone results were not adopted as clinical interaction guidance.

How this applies: Guarana seed constituent and safety context only, not a methamphetamine study.

Spontaneous reports cannot quantify risk; rat amiodarone findings do not establish a human methamphetamine interaction.

Source 4: original clinical study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 16 healthy adults.

Both active preparations increased pulse and blood pressure.

How this applies: Supports only the specific result and preparation described; applicability to prescribed oral methamphetamine is explicitly limited.

Ephedra-containing combination cannot isolate guarana effects; no methamphetamine. Not proof guarana alone causes the same response.

Source 5: official consumer guidance

fda.gov · Source check Sep 10, 2026

Population: Caffeine consumers, including adults and children.

Too much caffeine can cause palpitations, increased heart rate, anxiety and sleep problems. Sensitivity varies; medicines and health conditions can matter.

How this applies: Supports reviewing total caffeine and individual susceptibility without claiming every amount is unsafe.

General caffeine guidance is not a methamphetamine-specific safe intake limit.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Current available claims adjudicated from inspected sources; no clinical review asserted.
Research summary published

Article revision: 69d0a90bc1ba3a6b

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.